ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Biogen MS drug hit by EU safety restriction
pharmaphorum
July 11, 2017Biogen’s Zinbryta multiple sclerosis drug has suffered a serious setback after European regulators restricted its use because of liver safety concerns.
Pharma Sources Insight July 2025
